Servier $2.4 billion acquisition of Shire oncology business

16/4/2018

Private acquisition

Value:

$ 2.4 billion

Status:

Announced

Date:

16/4/2018

Overview:

Pharmaceutical company Servier has agreed to acquire the oncology business of Shire, a leading global biotechnology company focused on rare diseases, for $2.4 billion.

Prin Shasiharan - Researcher

Jurisdictions:

United States
France
Ukraine

Deal type:

Private acquisition

Practice area:

M&A

Industry sector:

Pharmaceuticals and life sciences

Firms:

Baker McKenzie

Party: Servier (Acquirer)

Lawyers: Hugo Sanchez de la Espada, Olha Demianiuk, Stéphane Davin

Davis Polk & Wardwell

Party: Shire (Seller)

Lawyer: William Chudd

Hogan Lovells

Party: Shire (Seller)

Lawyers: Birgit Reese, Mahvesh Qureshi, Xavier Doumen

Schellenberg Wittmer

Party: Shire (Seller)

Lawyers: Josef Caleff, Pascal Hubli

Related deals